The COBAS 6800 Fully Automated Molecular System (FMS), is capable of processing 1,000 swab samples per day.
The national COVID-19 task force launched a new swab testing machine on Thursday.
Called the COBAS 6800 Fully Automated Molecular System (FMS), the machine is capable of processing 1,000 samples per day.
The COBAS 6800 FMS is the second COVID-19 detection machine developed in Indonesia. It uses nucleic acid amplification testing (NAAT) to detect the presence of SARS-CoV-2.
During a launch event at the Eijkman Institute for Molecular Biology in Salemba, Central Jakarta, Research and Technology Minister Bambang Brodjonegoro said he hoped the machine would be able to increase COVID-19 testing in Indonesia.
Read also: Researchers consider options for eventual COVID-19 immunity certification
“We are so proud of the Eijkman Institute for making an innovation today with the COBAS 6800 FMS machine,” Bambang said.
Eijkman Institute chairman Amin Soebandrio said the machine operated automatically and did not require human intervention.
“The machine is fully automatic, which means it's controlled and guaranteed to produce high-quality results faster. That’s why we are capable of testing 1,000 samples every day,” Amin said.
Separately, National Disaster Mitigation Agency (BNPB) chief inspector Tetty Saragih expressed his support for the new machine.
“We are really proud of the machine,” Tetty said.
Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.
Thank you for sharing your thoughts. We appreciate your feedback.
Quickly share this news with your network—keep everyone informed with just a single click!
Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
Get the best experience—faster access, exclusive features, and a seamless way to stay updated.